BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Perng P, Zampella JG, Okoye GA. Management of hidradenitis suppurativa in pregnancy. Journal of the American Academy of Dermatology 2017;76:979-89. [DOI: 10.1016/j.jaad.2016.10.032] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Abdel Azim AA, Salem RT, Abdelghani R. Combined fractional carbon dioxide laser and long-pulsed neodymium : yttrium-aluminium-garnet (1064 nm) laser in treatment of hidradenitis suppurativa; a prospective randomized intra-individual controlled study. Int J Dermatol 2018;57:1135-44. [DOI: 10.1111/ijd.14075] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
2 Nasca MR, Giuffrida G, Micali G. The Influence of Pregnancy on the Clinical Evolution and Prognosis of Pre-Existing Inflammatory and Autoimmune Skin Disorders and Their Management. Dermatology 2021;237:771-85. [PMID: 32950977 DOI: 10.1159/000509726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Montero-Vilchez T, Salvador-Rodriguez L, Rodriguez-Tejero A, Sanchez-Diaz M, Arias-Santiago S, Molina-Leyva A. Reproductive Potential and Outcomes in Patients with Hidradenitis Suppurativa: Clinical Profile and Therapeutic Implications. Life (Basel) 2021;11:277. [PMID: 33810294 DOI: 10.3390/life11040277] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, Crowell K, Eisen DB, Gottlieb AB, Hamzavi I, Hazen PG, Jaleel T, Kimball AB, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Journal of the American Academy of Dermatology 2019;81:91-101. [DOI: 10.1016/j.jaad.2019.02.068] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 19.3] [Reference Citation Analysis]
5 Adelekun AA, Micheletti RG, Hsiao JL. Creation of a Registry to Address Knowledge Gaps in Hidradenitis Suppurativa and Pregnancy. JAMA Dermatol 2020;156:353. [DOI: 10.1001/jamadermatol.2019.4162] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
6 Collier EK, Seivright JR, Shi VY, Hsiao JL. Pregnancy and breastfeeding in hidradenitis suppurativa: A review of medication safety. Dermatol Ther 2021;34:e14674. [PMID: 33320387 DOI: 10.1111/dth.14674] [Reference Citation Analysis]
7 Fernandez JM, Hendricks AJ, Thompson AM, Mata EM, Collier EK, Grogan TR, Shi VY, Hsiao JL. Menses, pregnancy, delivery, and menopause in hidradenitis suppurativa: A patient survey. Int J Womens Dermatol 2020;6:368-71. [PMID: 33898700 DOI: 10.1016/j.ijwd.2020.07.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Samuel S, Tremelling A, Murray M. Presentation and surgical management of hidradenitis suppurativa of the breast during pregnancy: A case report. Int J Surg Case Rep 2018;51:21-4. [PMID: 30130669 DOI: 10.1016/j.ijscr.2018.08.013] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Lyons AB, Peacock A, McKenzie SA, Jacobsen G, Naik HB, Shi VY, Hamzavi IH, Hsiao JL. Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum. JAMA Dermatol 2020;156:681-5. [PMID: 32347884 DOI: 10.1001/jamadermatol.2020.0777] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
10 Chang JE, Choi MS. A Molecular Perspective on the Potential Benefits of Metformin for the Treatment of Inflammatory Skin Disorders. Int J Mol Sci 2020;21:E8960. [PMID: 33255783 DOI: 10.3390/ijms21238960] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Sayed CJ, Hsiao JL, Okun MM; Hidradenitis Suppurativa Foundation Women's Health Subcommittee. Clinical Epidemiology and Management of Hidradenitis Suppurativa. Obstet Gynecol 2021;137:731-46. [PMID: 33706337 DOI: 10.1097/AOG.0000000000004321] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Collier E, Shi VY, Parvataneni RK, Lowes MA, Hsiao JL. Special considerations for women with hidradenitis suppurativa. Int J Womens Dermatol 2020;6:85-8. [PMID: 32258337 DOI: 10.1016/j.ijwd.2020.02.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
13 Stewart KM. Challenging Ulcerative Vulvar Conditions. Obstetrics and Gynecology Clinics of North America 2017;44:453-73. [DOI: 10.1016/j.ogc.2017.05.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
14 Wohlmuth-Wieser I, Alhusayen R. Treatment of hidradenitis suppurativa with certolizumab pegol during pregnancy. Int J Dermatol 2021;60:e140-1. [PMID: 33247833 DOI: 10.1111/ijd.15286] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
15 Sakya SM, Hallan DR, Maczuga SA, Kirby JS. Outcomes of pregnancy and childbirth in women with hidradenitis suppurativa. J Am Acad Dermatol 2021:S0190-9622(21)01984-8. [PMID: 34153386 DOI: 10.1016/j.jaad.2021.05.059] [Reference Citation Analysis]
16 Darch KM, Holland TL, Spelman LJ. Hidradenitis Suppurativa Recurrence in a Caesarean Scar. Case Rep Obstet Gynecol 2020;2020:6283720. [PMID: 32566337 DOI: 10.1155/2020/6283720] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Repetto F, Burzi L, Ramondetta A, Rozzo G, Licciardello M, Ribero S, Quaglino P, Dapavo P. Certolizumab pegol and its role in pregnancy-age hidradenitis suppurativa. Int J Dermatol 2021. [PMID: 34270087 DOI: 10.1111/ijd.15742] [Reference Citation Analysis]
18 Molinelli E, Sapigni C, Campanati A, Brisigotti V, Offidani A. Metabolic, pharmacokinetic, and toxicological issues of biologic therapies currently used in the treatment of hidradenitis suppurativa. Expert Opin Drug Metab Toxicol 2020;16:1019-37. [PMID: 32896186 DOI: 10.1080/17425255.2020.1810233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]